Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials
暂无分享,去创建一个
M. Gasparri | C. Marchetti | V. Tombolini | L. Muzii | P. Panici | D. Musio | I. Palaia | V. Di Donato | F. De Felice | A. Musella